Seventeen patients (13.8%) carried a GPV in HBOP cancer predisposition genes, including only a single carrier of GPV in BRCA1 and BRCA2, respectively (2/123; 1.6%), compared to 30.2% GPV in population-matched OC patients published previously (Table 2)6. Here, BRCA2 is linked to cancer.